Next Article in Journal
Kinetic Spectrophotometric Determination of Isoxsuprine in Dosage Forms Through Derivatisation with 4-Chloro-7- nitrobenzo-2-oxa-1,3-diazole (NBD-Cl)
Previous Article in Journal
QSAR Study on Novel CCR5 Receptor Antagonists: An Insight into the Structural Requirement for the HIV Co Receptor Antagonist Activity
Article Menu

Article Versions

Export Article

Open AccessArticle
Sci. Pharm. 2008, 76(4), 621-636; doi:10.3797/scipharm.0806-14 (registering DOI)

Anticonvulsant and Sedative-Hypnotic Activities of N-Acetyl / Methyl Isatin Derivatives

1
Department of Pharmaceutical Analysis, C.L.Baid Metha College of Pharmacy, Rajiv Gandhi Salai, Thorapakkam, Chennai 600 096, India
2
Department of Pharmacy, Saroj Institute of Technology and Management, Arjunganj, Lucknow, 226 002, India
3
National Institute of Neurological Disorders and Stroke, NIH, Maryland, 20892-9020, USA
4
Department of Pathology, University of Texas Health Science Center at San Antonio, 7703, Floyd Curl Drive, San Antonio, Texas-78229, USA
*
Author to whom correspondence should be addressed.
Received: 30 June 2008 / Accepted: 14 September 2008 / Published: 17 September 2008
Download PDF [273 KB, uploaded 28 December 2016]

Abstract

A series of N-methyl/acetyl 5-(un)-substituted isatin-3-semicarbazones were screened for anticonvulsant and sedative-hypnotic activities. The results revealed that protection was obtained in all the screens i.e., Maximal electroshock, (MES) subcutaneous pentylene tetrazole (scPTZ) and subcutaneous strychnine (scSTY) screens. Three compounds (2a,2e and 2i) possessed anti-MES activity and all the compounds were less neurotoxic than phenytoin, carbamazepine and phenobarbital. All the compounds were completely non-toxic at 4h when compared to phenytoin, carbamazepine and phenobarbital, which were toxic at 100 and 300 mg/kg respectively. Compounds 2a, 2b, 2e, 2g and 2i emerged as the active compounds in oral MES screen. Selected compounds were evaluated for quantification studies in MES, scPTZ and neurotoxicity screens after i. p (2b, 2i) and oral administration (2a, 2g) in rats. Among all the compounds 2a, 2b and 2g emerged as broad-spectrum compounds as indicated by their protection in MES, scSTY and scPTZ screens. All the compounds except compound 2b showed significant sedative-hypnotic activity.
Keywords: Isatin-3-semicarbazones; Anticonvulsant; Maximal electroshock; Sedative-hypnotic Isatin-3-semicarbazones; Anticonvulsant; Maximal electroshock; Sedative-hypnotic
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

SMITHA, S.; PANDEYA, S.N.; STABLES, J.P.; GANAPATHY, S. Anticonvulsant and Sedative-Hypnotic Activities of N-Acetyl / Methyl Isatin Derivatives. Sci. Pharm. 2008, 76, 621-636.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top